Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

WARD Phase 3 chronic neutropenia trial in full swing; full enrollment on track for 3Q or 4Q 2025 and top-line data in 2H 2026 ...

Until recently, the choice of full-service outsourcing (FSO) vs functional service partnerships (FSP) most frequently was ...

At AUA 2025, experts will present on novel bladder cancer therapies, advanced renal cell carcinoma comparisons, frailty in ...

Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global ...

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...

The distinction between the two isn’t merely philosophical, but also existential. Identifying the right VC demands a ...

Enterprises around the world are turning to Microsoft's AI and cloud ecosystem to support projects that will help them navigate unpredictable markets, according to a new research report published ...

Regulatory delays could hinder Mind Medicine's patient access and market entry. Read why we are initiating coverage on MNMD ...

IT causes mood swings, bloating, headaches, skin issues and changes in appetite. Yet premenstrual syndrome (PMS) is often not taken seriously by medical professionals, peers, partners and ...

Blue Shield of California today announced the winners of the health plan's Stand for What's Right Awards, recognizing 10 nonprofit organizations for their dedication to improving youth mental health ...